Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gal
Amit Gal, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20080235640 | Method and apparatus for performing static analysis optimization in a design verification system - Method and apparatus for performing static analysis optimization in a design verification system is described. In one example, a description of a verification environment having constrained objects is obtained. The constrained objects are analyzed incrementally to create a data structure of nodes. Each node includes a description of variables transitively connected by constraints. At least one of the nodes reuses a description from at least one other node. The data structure is then used during logic design verification. | 09-25-2008 |
Catherine Gal, Verrieres-Le-Buisson FR
| Patent application number | Description | Published |
|---|---|---|
| 20110155602 | DEVICE FOR MONITORING THE REMOVAL OF ITEMS PLACED IN COMPARTMENTS OF A BLISTER PACKAGE, IN PARTICULAR TO ASSIST A PATIENT IN FOLLOWING A PRESCRIBED PROGRAMME OF MEDICATION - Described within is a device ( | 06-30-2011 |
Florent Gal, Labergement Les Seurre FR
| Patent application number | Description | Published |
|---|---|---|
| 20110221127 | SYSTEM FOR DEPOSITING DOCUMENTS INTO BOXES - The invention relates to a system adapted for printing and for consecutively placing in boxes moving on a conveyor, documents of the slip type ( | 09-15-2011 |
Krisztina Gal, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090042934 | Sulfonyl-Quinoline Derivatives - The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes and intermediates for their preparation, to pharmaceutical compositions containing these compounds and to their use in treatment and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors. | 02-12-2009 |
| 20090149495 | COMPOUNDS - The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) wherein X represents a group selected from CO, SO, SO | 06-11-2009 |
| 20090270371 | QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS - Compounds of formula (I): and/or enantiomers and/or racemates and/or diastereomers and/or pharmaceutically acceptable salts thereof formed with acids or bases, to the process for their preparation, to the intermediates of the preparation process, to the pharmaceutical formulations containing these compounds and to their use in the prevention and/or treatment of mGluR5 receptor-mediated disorders. | 10-29-2009 |
| 20090326001 | THIENOPYRIDINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS - The present invention relates to new mGluR1 and niGluR5 receptor subtype preferring ligands of formula (I): wherein X represents a group selected from (CH | 12-31-2009 |
| 20100022521 | COMPOUNDS - The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) wherein X represents a group selected from SO, SO2; Y represents a group selected from (CH | 01-28-2010 |
| 20110184014 | NEW COMPOUNDS - The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I); wherein Y represents a substituent selected from hydrogen, methyl, fluoro, chloro, bromo, methoxy; Z is hydrogen or methyl; R is an optionally substituted heteroaryl, and/or salts and/or hydrates and/or solvates thereof, to the processes for producing the same, to pharmaceutical compositions containing the same and to their use in therapy and/or prevention of pathological conditions which require the modulation of mGluR1 and mGluR5 receptors such as neurological disorders, psychiatric disorders, acute and chronic pain and neuromuscular dysfunctions of the lower urinary tract. | 07-28-2011 |
Michael Gal, Engadine AU
| Patent application number | Description | Published |
|---|---|---|
| 20090117339 | METHOD OF COMPONENT ASSEMBLY ON A SUBSTRATE - A method of component assembly on a substrate, and an assembly of a bound component on a substrate. The method comprises the steps of forming a free-standing component having an optical characteristic; providing a pattern of a first binding species on the substrate or the free standing component; and forming a bound component on the substrate through a binding interaction via the first binding species; wherein the bound component exhibits substantially the same optical characteristic compared to the free-standing component. | 05-07-2009 |
Michael Gal, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20100279394 | METHOD OF COMPONENT ASSEMBLY ON A SUBSTRATE - A method of component assembly on a substrate, and an assembly of a bound component on a substrate. The method comprises the steps of forming a free-standing component having an optical characteristic; providing a pattern of a first binding species on the substrate or the free standing component; and forming a bound component on the substrate through a binding interaction via the first binding species; wherein the bound component exhibits substantially the same optical characteristic compared to the free-standing component. | 11-04-2010 |
Peter Gal, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090042248 | FOLDED RECOMBINANT CATALYTIC FRAGMENTS OF MULTIDOMAIN SERINE PROTEASES, PREPARATION AND USES THEREOF - The invention relates to unglycosylated folded C-terminal fragments of a multidomain serine protease of the complement cascade obtainable by expression in a bacterial host, wherein said serine protease is capable of binding a recognition molecule of the complement cascade, e.g. C1 or MBL. The invention also relates to methods and bacterial expression vectors for the preparation of said fragments, uses of said fragments for raising antibodies and screening substrates or inhibitors of said serine proteases and uses of the fragments in research and treatment of complement related disorders. The invention also relates to assay methods for assessing MASP-1 and MASP-2 levels in a sample of biological origin. | 02-12-2009 |
Sang Wan Gal, Gyeongsangnam-Do KR
| Patent application number | Description | Published |
|---|---|---|
| 20090252694 | Novel Chalcone Derivatives, Pharmaceutically Acceptable Salt, Method for Preparation and Uses Thereof - Disclosed relates to a novel chalcone derivative, pharmaceutically acceptable salt thereof, a method for preparing the same and uses thereof, the chalcone derivative being readily obtained through the steps of: reacting aminoacetophenone with sulfonylchloride under the presence of an appropriate salt; and reacting the compound prepared in the above step with hydroxybenzaldehide under the presence of an appropriate catalyst. The chalcone derivative of formula 1 in accordance with the present invention having strong enzyme inhibitory activities for glycosidase can be effectively used in preventing and treating various diseases induced by glycosidase, and the chalcone derivative of the invention having tyrosinase and melanin synthesis inhibitory activities can be effectively used as a skin-whitening compound. | 10-08-2009 |
Wilhelmus Gerardus Jozef Gal, Kilder NL
| Patent application number | Description | Published |
|---|---|---|
| 20090115098 | Mould Part and Method for Encapsulating Electronic Components - The invention relates to a mould part for applying in a device for encapsulating electronic components mounted on a carrier, comprising: at least one mould cavity recessed into a contact side, a contact surface at least partially enclosing the mould cavity for medium-tight connection to the carrier of the electronic component, a feed channel for encapsulating material recessed into the contact surface and connecting to the mould cavity, a first outlet channel for gas, and an extraction space recessed into the contact surface. The invention also relates to a device for encapsulating electronic components mounted on a carrier and to a method for encapsulating electronic components mounted on a carrier. | 05-07-2009 |